Integrated Wound-Care Centres To Boost Treatment, Monitoring Of Chronic Wounds

India’s IHLD MedTech is rolling out specialised Wound Heal Plus centres across the country over the next two to three years to tackle chronic wounds, particularly diabetic foot ulcers. The initiative, funded by a $3 million investment from Singapore-listed UltraGreen.ai, aims to provide integrated diagnosis, treatment, and long-term monitoring for patients with non-healing wounds. The funding may grow to $12 million based on milestones, supporting expansion of both the centres and the iLiveConnect platform, an AI-enabled continuity-care system. The centres will consolidate wound screening, advanced imaging, treatment, and rehabilitation under one roof, addressing a neglected area of healthcare. iLiveConnect uses wearable biosensors, predictive analytics, and physician oversight to detect early signs of medical deterioration and enable timely intervention. Dr Rahul Chandola, founder of IHLD MedTech, noted that India’s diabetes epidemic—with complications like neuropathy and poor circulation—leads to millions of chronic wounds, often resulting in amputations if untreated. A multidisciplinary team, including vascular surgeons, podiatrists, and nutritionists, will manage patient care. The centres will employ advanced fluorescence imaging technology, analysed via WoundLinks software, to assess blood flow and tissue perfusion, improving treatment precision. After discharge, patients will continue care through iLiveConnect’s digital monitoring system. UltraGreen.ai’s CEO, Ravinder Sajwan, highlighted the potential of merging technology and clinical expertise to improve patient outcomes. The initiative targets India’s diabetes burden, where complications like diabetic foot ulcers severely impact quality of life. The centres aim to bridge gaps in wound care by offering comprehensive, tech-driven solutions for long-term patient management.